Increasing preference for vegetarian capsules in the nutraceutical and pharmaceutical industries is expected to rev up demand for the HPMC capsules globally. In addition, the non-animal and vegetarian capsules are likely to witness significant demand for in the pharmaceutical industry. Such factors are likely to contribute towards growth of the global HPMC capsules market. Persistence Market Research has recently published a report, which reveals that the global HPMC capsules market is expected to register an impressive CAGR of 10.9% over the forecast period, 2017-2025.
Growing need to improve the formulation design in the nutraceutical and pharmaceutical industries is expected to rev up demand for the HPMC capsules globally. Moreover, increasing demand for vegetarian capsules that are well-suited for nutrient supplement, hydroscopic drug, and have relatively low moisture in the pharmaceutical industry is likely to impact growth of the global market positively. Manufacturers are also expected to generate significant revenues by providing vegetarian technologies with the liquid filling technology in the nutraceutical industry. In an attempt to expand their revenue base, the HPMC capsules are increasingly providing customized clinical trials. These factors are likely to impact growth of the global market positively.
In addition, emergence of manufacturing technology and enhanced research are expected to reduce the risk of cross-contamination of various drugs and provide a convenient techniques of processing. These factors are lowering the cost related to complex engineering controls and ensure the uniformity in the products. Attributed to low side effects and suitability among patients in various stages including prevention, treatment, and diagnosis, demand for the HPMC capsules are likely to rev up during the forecast period.
As these capsules are certified as a non-toxic drug by Kosher and Halal, the HPMC capsules are becoming more efficient and reliable in the pharmaceutical industry. These factors are likely to impact growth of the global market positively.
The HPMC capsules with gelling aids are likely to account for around two-third of the revenue share in the global market by the end of 2017. These capsules are likely to witness considerable demand throughout the forecast period. By 2025-end, nearly 118,989 Mn units of the HPMC medicines with the gelling aid are likely to be manufactured. Food and beverages among other end users are likely to represent a leading segment. This segment is expected to represent nearly US$ 358.8 Mn revenues in terms of sales in the global market by the end of 2025.
North America among other regions is expected to account for a revenue share of 41.7% in 2016. The market in North America is likely to remain dominant over the forecast period. Europe among other regions will continue to witness significantly high demand throughout the forecast period. Moreover, the market in Europe is expected to register the highest CAGR in the global market through 2025.
Leading players in the global HPMC capsules market include Qualicaps LLC, Capsugel, ACG Worldwide, CapsCanada, Bright Pharma Caps, Inc., Sunil Healthcare Limited, BioCaps Enterprise, Inc., Suheung Co., Ltd., Baotou Capstech Co., Ltd, HealthCaps India Ltd, Shanghai Honest Chemical Co., Ltd., Wuhan Carma Technology Co., Ltd, Shaoxing Kangke Capsule Co., Ltd., Strohcaps, Inc., GS Capsule, Zhejiang Yuexi Capsule Co., Ltd., Excellent Health Products Co., Ltd, Natural Capsules Limited, Farmacapsulas SA, and JC Empty Capsules.
Request and Download Sample Report@ https://www.persistencemarketresearch.com/samples/14512